{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:13:21Z","timestamp":1757618001429,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40744-025-00770-w","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:40:29Z","timestamp":1748583629000},"page":"731-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Lupus Check\u00a05 Tool: A Practical Approach to Initiating Treatment Reviews in Systemic Lupus Erythematosus"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-5023","authenticated-orcid":false,"given":"Anca","family":"Askanase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2696-031X","authenticated-orcid":false,"given":"Antonis","family":"Fanouriakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7585-5690","authenticated-orcid":false,"given":"Lyra","family":"Agustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Dall\u2019Era","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-7139","authenticated-orcid":false,"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"770_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-022-02756-3","volume":"24","author":"R Kandane-Rathnayake","year":"2022","unstructured":"Kandane-Rathnayake R, Louthrenoo W, Hoi A, et al. \u201cNot at target\u201d: prevalence and consequences of inadequate disease control in systemic lupus erythematosus\u2014a multinational observational cohort study. Arthritis Res Ther. 2022;24:70.","journal-title":"Arthritis Res Ther"},{"key":"770_CR2","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/rheumatology\/keab005","volume":"60","author":"J Mucke","year":"2021","unstructured":"Mucke J, D\u00fcsing C, Klose N, Schneider M, Chehab G. Remission in SLE\u2014do DORIS criteria match the treating physician\u2019s judgment? A cross-sectional study to assess reasons for discordance. Rheumatology (Oxford). 2021;60:4298\u2013305.","journal-title":"Rheumatology (Oxford)"},{"key":"770_CR3","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/jcm11133587","volume":"11","author":"M Gerosa","year":"2022","unstructured":"Gerosa M, Beretta L, Ramirez GA, et al. Long-term clinical outcome in systemic lupus erythematosus patients followed for more than 20\u00a0years: the Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort. J Clin Med. 2022;11:3587.","journal-title":"J Clin Med"},{"key":"770_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41584-021-00739-3","volume":"18","author":"AR Parra S\u00e1nchez","year":"2022","unstructured":"Parra S\u00e1nchez AR, Voskuyl AE, van Vollenhoven RF. Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat Rev Rheumatol. 2022;18:146\u201357.","journal-title":"Nat Rev Rheumatol"},{"key":"770_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000553","volume":"9","author":"Y Hao","year":"2022","unstructured":"Hao Y, Ji L, Gao D, et al. Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study. Lupus Sci Med. 2022;9:e000553.","journal-title":"Lupus Sci Med"},{"key":"770_CR6","doi-asserted-by":"publisher","first-page":"e822","DOI":"10.1016\/S2665-9913(22)00304-6","volume":"4","author":"R Kandane-Rathnayake","year":"2022","unstructured":"Kandane-Rathnayake R, Golder V, Louthrenoo W, et al. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study. Lancet Rheumatol. 2022;4:e822\u201330.","journal-title":"Lancet Rheumatol"},{"key":"770_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3899\/jrheum.170072","volume":"44","author":"K Gu","year":"2017","unstructured":"Gu K, Gladman DD, Su J, Urowitz MB. Hospitalizations in patients with systemic lupus erythematosus in an academic health science center. J Rheumatol. 2017;44:1173\u20138.","journal-title":"J Rheumatol"},{"key":"770_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","volume":"27","author":"N Costedoat-Chalumeau","year":"2013","unstructured":"Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, et al. Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol. 2013;27:329\u201340.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"770_CR9","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/jcm11071857","volume":"11","author":"S Emamikia","year":"2022","unstructured":"Emamikia S, Gentline C, Enman Y, Parodis I. How can we enhance adherence to medications in patients with systemic lupus erythematosus? Results from a qualitative study. J Clin Med. 2022;11:1857.","journal-title":"J Clin Med"},{"key":"770_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001207","volume":"11","author":"C Tani","year":"2024","unstructured":"Tani C, Maffi M, Cascarano G, et al. When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus. Lupus Sci Med. 2024;11: e001207.","journal-title":"Lupus Sci Med"},{"key":"770_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102615","volume":"119","author":"A Thanou","year":"2021","unstructured":"Thanou A, Jupe E, Purushothaman M, Niewold TB, Munroe ME. Clinical disease activity and flare in SLE: current concepts and novel biomarkers. J Autoimmun. 2021;119:102615.","journal-title":"J Autoimmun"},{"key":"770_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15\u201329.","journal-title":"Ann Rheum Dis"},{"key":"770_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/rheumatology\/keac409","volume":"62","author":"R du Toit","year":"2023","unstructured":"du Toit R, Karamchand S, Doubell AF, Reuter H, Herbst PG. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice. Rheumatology (Oxford). 2023;62:523\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"770_CR14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/09612033231175782","volume":"32","author":"M Mu\u00f1oz-Urbano","year":"2023","unstructured":"Mu\u00f1oz-Urbano M, Sanchez-Bautista J, Ram\u00edrez A, et al. Lupus enteritis: a 10-year experience in a single Latin American center. Lupus. 2023;32:910\u20139.","journal-title":"Lupus"},{"key":"770_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736\u201345.","journal-title":"Ann Rheum Dis"},{"key":"770_CR16","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S2665-9913(21)00009-6","volume":"3","author":"CC Mok","year":"2021","unstructured":"Mok CC, Hamijoyo L, Kasitanon N, et al. The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus. Lancet Rheumatol. 2021;3:e517\u201331.","journal-title":"Lancet Rheumatol"},{"key":"770_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.31138\/mjr.28.1.4","volume":"28","author":"C Adamichou","year":"2017","unstructured":"Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017;28:4\u201312.","journal-title":"Mediterr J Rheumatol"},{"key":"770_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjh.14478","volume":"176","author":"QA Hill","year":"2017","unstructured":"Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017;176:395\u2013411.","journal-title":"Br J Haematol"},{"key":"770_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5152\/eurjrheum.2023.23069","volume":"10","author":"ON Pamuk","year":"2023","unstructured":"Pamuk ON. Thrombocytopenia in patients with systemic lupus erythematosus. Eur J Rheumatol. 2023;10:159\u201362.","journal-title":"Eur J Rheumatol"},{"key":"770_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/09612033231163745","volume":"32","author":"LA Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez LA, Alarc\u00f3n GS, Harvey GB, et al. Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: data from a multiethnic Latin American cohort. Lupus. 2023;32:658\u201367.","journal-title":"Lupus"},{"key":"770_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000173","volume":"4","author":"P Ngamjanyaporn","year":"2017","unstructured":"Ngamjanyaporn P, McCarthy EM, Sergeant JC, et al. Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey. Lupus Sci Med. 2017;4:e000173.","journal-title":"Lupus Sci Med"},{"key":"770_CR22","first-page":"275","volume":"26","author":"P Katz","year":"2020","unstructured":"Katz P, Nelson WW, Daly RP, Topf L, Connolly-Strong E, Reed ML. Patient-reported lupus flare symptoms are associated with worsened patient outcomes and increased economic burden. J Manag Care Spec Pharm. 2020;26:275\u201383.","journal-title":"J Manag Care Spec Pharm"},{"key":"770_CR23","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","volume":"59","author":"G Ruiz-Irastorza","year":"2020","unstructured":"Ruiz-Irastorza G, Bertsias G. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatology (Oxford). 2020;59:v69-81.","journal-title":"Rheumatology (Oxford)"},{"key":"770_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10067-016-3492-6","volume":"36","author":"T Tarr","year":"2017","unstructured":"Tarr T, Papp G, Nagy N, Cser\u00e9p E, Zeher M. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus. Clin Rheumatol. 2017;36:327\u201333.","journal-title":"Clin Rheumatol"},{"key":"770_CR25","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/annrheumdis-2018-213512","volume":"77","author":"BA Pons-Estel","year":"2018","unstructured":"Pons-Estel BA, Bonfa E, Soriano ER, et al. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR). Ann Rheum Dis. 2018;77:1549\u201357.","journal-title":"Ann Rheum Dis"},{"key":"770_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/ard-2023-225369","volume":"83","author":"Y Katsumata","year":"2024","unstructured":"Katsumata Y, Inoue E, Harigai M, et al. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Ann Rheum Dis. 2024;83:998\u20131005.","journal-title":"Ann Rheum Dis"},{"key":"770_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0961203317722412","volume":"27","author":"V Golder","year":"2018","unstructured":"Golder V, Ooi JJ, Antony AS, et al. Discordance of patient and physician health status concerns in systemic lupus erythematosus. Lupus. 2018;27:501\u20136.","journal-title":"Lupus"},{"key":"770_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000469","volume":"8","author":"A Cornet","year":"2021","unstructured":"Cornet A, Andersen J, Myllys K, Edwards A, Arnaud L. Living with systemic lupus erythematosus in 2020: a European patient survey. Lupus Sci Med. 2021;8:e000469.","journal-title":"Lupus Sci Med"},{"key":"770_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001202","volume":"11","author":"E Elefante","year":"2024","unstructured":"Elefante E, Gualtieri L, Schilir\u00f2 D, et al. Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE). Lupus Sci Med. 2024;11:e001202.","journal-title":"Lupus Sci Med"},{"key":"770_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, et al. American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72:529\u201356.","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00770-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-025-00770-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00770-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T16:26:39Z","timestamp":1757175999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-025-00770-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s40744-025-00770-w","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"type":"print","value":"2198-6576"},{"type":"electronic","value":"2198-6584"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anca Askanase has received grants or contracts from Alumis, AstraZeneca, Bristol Myers Squibb, Cabaletta Bio, Idorsia, Nkarta, Sanofi, and UCB; consulting fees from AstraZeneca, GSK, and Novartis; and has participated on a Data Safety Monitoring Board or Advisory Board with Amgen and Janssen. Antonis Fanouriakis has received grants or contracts from AstraZeneca, and payment or honoraria from AstraZeneca and GSK. Lyra Agustin is an employee of AstraZeneca. Maria Dall\u2019Era has nothing to disclose. Marta Mosca has received grants or contracts from GSK; consulting fees from AbbVie, AstraZeneca, BMS, and GSK; payment or honoraria from AstraZeneca, Eli Lilly, and GSK; has participated on a Data Safety Monitoring Board or Advisory Board with Idorsia and Miltenyi Biotec; and has worked in a leadership or fiduciary role with EMA. Yoshiya Tanaka has received grants from Boehringer Ingelheim, Chugai Pharma, and Taisho Pharmaceutical, and speaker payment and\/or honoraria from AbbVie, Asahi Kasei, Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Chugai Pharma, Daiichi Sankyo, Eisai, Eli Lilly, Gilead Sciences, GSK, Pfizer, Taisho Pharmaceutical, and UCB. Anca Askanase and Yoshiya Tanaka are Editorial Board members of Rheumatology and Therapy. Anca Askanase and Yoshiya Tanaka were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}